Interactions of the Antimalarial Drug Methylene Blue with Methemoglobin and Heme Targets in Plasmodium falciparum: A Physico-Biochemical Study
Interactions of the Antimalarial Drug Methylene Blue with Methemoglobin and Heme Targets in Plasmodium falciparum: A Physico-Biochemical Study
复制标题
DOI:
10.1089/ars.2011.4239
复制
发表时间:
2012-08-01
影响因子:
6.6
通讯作者:
Elhabiri, Mourad
中科院分区:
文献类型:
--
作者:
Blank, Olga;Davioud-Charvet, Elisabeth;Elhabiri, Mourad
Aims: Resistance of Plasmodium falciparum to drugs has led to renewed interest of redox-active methylene blue (MB) for which no resistance has been reported so far. Moreover, MB displays unique interactions with glutathione reductase (GR). However, the mechanisms of action/interaction with potential targets of MB are yet to be elucidated. Our physico-biochemical study on MB and relevant hematin-containing targets was performed under quasi-physiological conditions. Results: The water deprotonation of the Fe(III) protoporphyrin dimer, the major building block of beta-hematin, was studied. At pH 6, the predominant dimer possesses water coordinated to both metals. Below pH 6, spontaneous precipitation of beta-hematin occurred reminiscent of hemozoin biomineralization at pH 5.0-5.5 in the food vacuole of the malarial parasite. MB also forms dimers (K-Dim = 6800 M-1) and firmly binds to hematin in a 2: 1 hematin: MB sandwich complex (K-D = 3.16 mu M). MB bioactivation catalyzed by GR induces efficient methemoglobin(Fe-III) [metHb(Fe-III)] reduction to hemoglobin(Fe-II). The reduction rate, mediated by leucomethylene blue (LMB), was determined (k(red)(metHb) = 991 M-1.s(-1)) in an assay coupled to the GR/reduced form of nicotinamide adenine dinucleotide phosphate system. Innovation and Conclusion: Our work provides new insights into the understanding of (i) how MB interacts with hematin-containing targets, (ii) other relevant MB properties in corroboration with the distribution of the three major LMB species as a function of pH, and (iii) how this redox-active cycler induces efficient catalytic reduction of metHb(Fe-III) to hemoglobin(Fe-II) mediated by oxidoreductases. These physico-biochemical parameters of MB open promising perspectives for the interpretation of the pharmacology and pathophysiology of malaria and possibly new routes for antimalarial drug development. Antioxid. Redox Signal. 17, 544-554.